Cutler Group LP Homology Medicines, Inc. Call Options Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 Apr 26, 2021	SELL	$9.17 - $14.8 $4,585 - $7,400	-500 Reduced 62.5%	300 $0
Q4 2020 Jan 21, 2021	SELL	$8.92 - $13.29 $10,704 - $15,947	-1,200 Reduced 60.0%	800 $1,000
Q3 2020 Oct 27, 2020	SELL	$9.94 - $16.59 $9,940 - $16,590	-1,000 Reduced 33.33%	2,000 $0
Q2 2020 Jul 22, 2020	BUY	$12.07 - $19.34 $31,382 - $50,284	2,600 Added 650.0%	3,000 $3,000
Q4 2019 Feb 06, 2020	BUY	$11.42 - $22.19 $4,568 - $8,876	400 New	400 $1,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.